Reishi (Ganoderma multipileum) is one of the most respected medicinal mushrooms in traditional and modern medicine. Known for its potent bioactive compounds—including triterpenoids and polysaccharides—Reishi is widely studied for its immune-boosting, anti-inflammatory, antioxidant, and liver-supportive properties.
This agar culture offers a clean, fast-growing foundation for Reishi cultivation. It’s ideal for growers, researchers, and product developers seeking consistent colonisation and high bioactive yields.
What You’ll Receive
- 1 × 100 mm sterile agar plate fully colonised with G. lucidum mycelium
- Sector-free growth on nutrient-rich agar
- Poured and sealed under sterile conditions
- Strain ID and pour date labeled for traceability
- Best used within 4 weeks (store at 2–5 °C)
Growth & Cultivation Info
- Colonisation temperature: 24–28 °C (in dark or low light)
- Fruiting temperature: 22–26 °C with 90–95% RH
- Light: Indirect natural or 6500K LED for conk formation
- Air exchange: High CO₂ promotes antler form; fresh air promotes classic shelf-like conks
- Substrates: Supplemented hardwood sawdust, rice bran, or agricultural waste blends
Functional & Commercial Value
Reishi’s health benefits are backed by decades of pharmacological studies. Compounds like ganoderic acids (triterpenes) and β-glucans (polysaccharides) are linked to immune modulation, stress regulation, liver detoxification, and anti-aging effects. This makes it a staple in supplements, teas, and tincture lines across global markets.
Recommended Uses
- Expand to grain spawn for bulk substrate inoculation
- Maintain in a culture library for ongoing R&D
- Produce fruiting bodies for dried powder, extract, or tea applications
- Support bioactive compound studies in laboratory environments
This agar plate delivers the consistency, purity, and performance needed to grow high-value medicinal mushrooms. Whether you’re scaling production or developing a new functional formula, it all starts with clean, reliable mycelium.







Reviews
There are no reviews yet.